Prognostic value of heart rate variability after acute myocardial infarction

Area of Science:

• Cardiology
• Autonomic Nervous System Research
• Medical Prognostics

Background:

• Prognosis after acute myocardial infarction (AMI) may be influenced by autonomic dysfunction, assessed via heart rate variability (HRV).
• Previous studies on HRV's predictive value predated widespread reperfusion therapy for AMI.
• This study evaluates HRV parameters one year post-AMI in patients treated conventionally versus with reperfusion.

Purpose of the Study:

• To assess the prognostic value of heart rate variability (HRV) parameters one year after acute myocardial infarction (AMI).
• To determine if HRV retains prognostic utility in patients treated with reperfusion therapy.
• To identify HRV parameters that independently predict mortality post-AMI.

Main Methods:

• Included 463 AMI patients (60.6±13.0 years); 211 received reperfusion (thrombolysis/PTCA), 251 conventional therapy.
• Calculated time-domain (SDNN, rMSSD) and frequency-domain (LF, HF, total power) HRV from 24-hour Holter ECGs 10-20 days post-AMI.
• Primary endpoint: one-year total mortality and sudden cardiac death.

Main Results:

• Cardiac death incidence was 14.7%, sudden death 4.8%, both higher in conventionally treated patients.
• Reperfusion patients showed higher HRV parameters (SDNN, total power, rMSSD, HF power) than conventional.
• Independent predictors of 1-year survival: SDNN<50 msec, rMSSD<20 msec, LF/HF>2, non-sustained ventricular tachycardia, LVEF<40%.

Conclusions:

• HRV parameters are valuable prognostic indicators one year post-AMI, independent of LVEF and arrhythmias.
• Reperfusion therapy reduces mortality risk but does not diminish the prognostic utility of HRV.
• HRV assessment remains crucial for risk stratification after AMI, regardless of treatment strategy.